🇺🇸 FDA
Patent

US 9738629

Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

granted A61KA61K31/4178A61K31/4184

Quick answer

US patent 9738629 (Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE LAKE PHARMA CO., LTD.
Grant date
Tue Aug 22 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 17 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/4178, A61K31/4184, A61K45/06, A61P